Factory Supply Top Quality 99% Ticagrelor Cas 274693-27-5 With Best Price

Ticagrelor CAS 274693-27-5 is an oral antiplatelet drug that is used with low dose aspirin to decrease the risk of myocardial infarction and stroke in patients with acute coronary syndromes. Ticagrelor has been linked to rare instances of hypersensitivity reactions accompanied by mild liver injury. Ticagrelor CAS 274693-27-5 is a triazolopyrimidine that is an adenosine isostere; the cyclopentane ring is similar to ribose and the nitrogen-rich [1,2,3]triazolo[4,5-d]pyrimidine moiety resembles the nucleobase adenine. A platelet aggregation inhibitor which is used for prevention of thromboembolic events in patients with acute coronary syndrome. It has a role as a platelet aggregation inhibitor and a P2Y12 receptor antagonist. It is a member of triazolopyrimidines, an organofluorine compound, an aryl sulfide, a secondary amino compound and a hydroxyether. Ticagrelor (trade name Brilinta in the US, Brilique and Possia in the EU) CAS 274693-27-5 is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.
Chat Now

Product Details

--2_01.png

Product Description

Name

Factory supply top quality 99% Ticagrelor cas 274693-27-5 with best price

Other name

Brilinta;Brilique ;

AZD6140 ;

(1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanedio

CAS

 274693-27-5

Applications

API

Appearance

White powder

  Ticagrelor CAS 274693-27-5 is an oral antiplatelet drug that is used with low dose aspirin to decrease the risk of myocardial infarction and stroke in patients with acute coronary syndromes. Ticagrelor has been linked to rare instances of hypersensitivity reactions accompanied by mild liver injury.

  Ticagrelor CAS 274693-27-5 is a triazolopyrimidine that is an adenosine isostere; the cyclopentane ring is similar to ribose and the nitrogen-rich [1,2,3]triazolo[4,5-d]pyrimidine moiety resembles the nucleobase adenine. A platelet aggregation inhibitor which is used for prevention of thromboembolic events in patients with acute coronary syndrome. It has a role as a platelet aggregation inhibitor and a P2Y12 receptor antagonist. It is a member of triazolopyrimidines, an organofluorine compound, an aryl sulfide, a secondary amino compound and a hydroxyether.

  Ticagrelor (trade name Brilinta in the US, Brilique and Possia in the EU) CAS 274693-27-5  is a platelet aggregation inhibitor produced by AstraZeneca. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011.

274693-27-5.jpg


Hot Tags: factory supply top quality 99% ticagrelor cas 274693-27-5 with best price, China, suppliers, manufacturers, factory, wholesale, bulk

Inquiry

You Might Also Like